Source: EIN Presswire

Press Release: Alzprotect : Alzprotect Establishes U.S. Subsidiary in Boston, in the Heart of the Biotech Cluster

Alzprotect, a biopharmaceutical company developing solutions for neurodegenerative diseases, announced today the creation of its U.S. subsidiary in Boston.LOOS, HDF, FRANCE, April 8, 2021 /⁨EINPresswire.com⁩/ -- Alzprotect establishes U.S. subsidiary in ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Philippe Verwaerde's photo - CEO of Alzprotect

CEO

Philippe Verwaerde

CEO Approval Rating

68/100

Read more